8-KThe WireRoutine
Reg FD Disclosure
Filed Jun 4, 2024 · 2y ago · Accession 0001558370-24-008882
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- CRESCENT BIOPHARMA, INC.
- Ticker
- CBIO
- CIK
- 1253689
- Form type
- 8-K
- Filing date
- Jun 4, 2024
- Report date
- Jun 4, 2024
- Document
- glyc-20240604x8k.htm
- Size
- 8.2 MB